Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus
(2004) In Arthritis Research and Therapy 6(2). p.87-94- Abstract
- This study was performed to investigate the relation between IgG autoantibodies against human C-reactive protein (antiCRP) and disease activity measures in serial serum samples from 10 patients with systemic lupus erythematosus (SLE), of whom four had active kidney involvement during the study period. The presence of anti-CRP was analysed by enzyme-linked immunosorbent assay. The cut-off for positive anti-CRP test was set at the 95th centile of 100 healthy blood donor sera. Specificity of the anti-CRP antibody binding was evaluated by preincubating patient sera with either native or monomeric CRP. Disease activity was determined by the SLE disease activity index (SLEDAI), serum levels of CRP, anti-DNA antibodies, complement components and... (More)
- This study was performed to investigate the relation between IgG autoantibodies against human C-reactive protein (antiCRP) and disease activity measures in serial serum samples from 10 patients with systemic lupus erythematosus (SLE), of whom four had active kidney involvement during the study period. The presence of anti-CRP was analysed by enzyme-linked immunosorbent assay. The cut-off for positive anti-CRP test was set at the 95th centile of 100 healthy blood donor sera. Specificity of the anti-CRP antibody binding was evaluated by preincubating patient sera with either native or monomeric CRP. Disease activity was determined by the SLE disease activity index (SLEDAI), serum levels of CRP, anti-DNA antibodies, complement components and blood cell counts. Of 50 serum samples, 20 (40%) contained antibodies reactive with monomeric CRP, and 7 of 10 patients were positive on at least one occasion during the study. All patients with active lupus nephritis were positive for anti-CRP at flare. Frequent correlations between anti-CRP levels and disease activity measures were observed in anti-CRP-positive individuals. Accumulated anti-CRP data from all patients were positively correlated with SLEDAI scores and anti-DNA antibody levels, whereas significant inverse relationships were noted for complement factors C1q, C3 and C4, and for lymphocyte counts. This study confirms the high prevalence of anti-CRP autoantibodies in SLE and that the antibody levels are correlated with clinical and laboratory disease activity measures. This indicates that anti-CRP antibodies might have biological functions of pathogenetic interest in SLE. Further prospective clinical studies and experimental studies on effects mediated by anti-CRP antibodies are warranted. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/287427
- author
- Sjowall, C ; Bengtsson, Anders LU ; Sturfelt, Gunnar LU and Skogh, T
- organization
- publishing date
- 2004
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- lupus erythematosus, systemic, SLEDAI, disease activity, autoantibodies, C-reactive protein
- in
- Arthritis Research and Therapy
- volume
- 6
- issue
- 2
- pages
- 87 - 94
- publisher
- BioMed Central (BMC)
- external identifiers
-
- wos:000189035200002
- scopus:27344435590
- pmid:15059271
- ISSN
- 1478-6362
- DOI
- 10.1186/ar1032
- language
- English
- LU publication?
- yes
- id
- bdc5ade5-8c74-4a68-b3a2-7d40384be993 (old id 287427)
- date added to LUP
- 2016-04-01 12:35:22
- date last changed
- 2022-01-27 07:11:46
@article{bdc5ade5-8c74-4a68-b3a2-7d40384be993,
abstract = {{This study was performed to investigate the relation between IgG autoantibodies against human C-reactive protein (antiCRP) and disease activity measures in serial serum samples from 10 patients with systemic lupus erythematosus (SLE), of whom four had active kidney involvement during the study period. The presence of anti-CRP was analysed by enzyme-linked immunosorbent assay. The cut-off for positive anti-CRP test was set at the 95th centile of 100 healthy blood donor sera. Specificity of the anti-CRP antibody binding was evaluated by preincubating patient sera with either native or monomeric CRP. Disease activity was determined by the SLE disease activity index (SLEDAI), serum levels of CRP, anti-DNA antibodies, complement components and blood cell counts. Of 50 serum samples, 20 (40%) contained antibodies reactive with monomeric CRP, and 7 of 10 patients were positive on at least one occasion during the study. All patients with active lupus nephritis were positive for anti-CRP at flare. Frequent correlations between anti-CRP levels and disease activity measures were observed in anti-CRP-positive individuals. Accumulated anti-CRP data from all patients were positively correlated with SLEDAI scores and anti-DNA antibody levels, whereas significant inverse relationships were noted for complement factors C1q, C3 and C4, and for lymphocyte counts. This study confirms the high prevalence of anti-CRP autoantibodies in SLE and that the antibody levels are correlated with clinical and laboratory disease activity measures. This indicates that anti-CRP antibodies might have biological functions of pathogenetic interest in SLE. Further prospective clinical studies and experimental studies on effects mediated by anti-CRP antibodies are warranted.}},
author = {{Sjowall, C and Bengtsson, Anders and Sturfelt, Gunnar and Skogh, T}},
issn = {{1478-6362}},
keywords = {{lupus erythematosus; systemic; SLEDAI; disease activity; autoantibodies; C-reactive protein}},
language = {{eng}},
number = {{2}},
pages = {{87--94}},
publisher = {{BioMed Central (BMC)}},
series = {{Arthritis Research and Therapy}},
title = {{Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus}},
url = {{http://dx.doi.org/10.1186/ar1032}},
doi = {{10.1186/ar1032}},
volume = {{6}},
year = {{2004}},
}